20 Jul 2012 12:36
Toumaz Limited
Result of EGM
Toumaz Limited (AIM: TMZ, 'Toumaz' or 'the Group'), a pioneer in and provider of ultra-low power, high-performance wireless communications technologies and solutions, is pleased to announce that at its EGM held earlier today, the Resolution described in the Company's announcement of 3 July 2012 and circular to shareholders of that date was passed.
Accordingly, authority has been obtained from Shareholders to disapply pre-emption rights in relation to the allotment of the Placing Shares. The Placing remains conditional upon, inter alia, the Acquisition Agreement becoming unconditional, which is expected to occur on 17 August 2012. First and Second Admission continue to be expected to be effective from 17 and 21 August 2012 respectively.
Terms and expressions defined in the announcement of 3 July 2012 have the same meaning in this announcement.
Enquiries:
Toumaz Limited | 01235 438950 |
Anthony Sethill, Chief Executive Officer
| |
FinnCap | |
Geoff Nash / Henrik Persson (Corporate Finance) | 020 7600 1658 |
Brian Patient (Corporate Broking) | |
College Hill | |
Adrian Duffield / Rozi Morris / Malar Veleigam | 020 7457 2020 |
About Toumaz - (www.toumazltd.com)
Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.
The Group has two businesses; Toumaz Healthcare covering health technology solutions, and Toumaz Microsystems covering the design and development of semiconductor chips and solutions for low power and high-performance wireless communication.
Toumaz Healthcare provides wireless healthcare monitoring solutions for the hospital and home health markets. Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.
Toumaz Microsystems designs, develops and sells low-power and high performance semiconductor chips and solutions for the growing embedded wireless connectivity market, addressing opportunities in a wide range of internet connected devices. These include home and enterprise automation, healthcare, smart power, security/monitoring systems, intelligent toys and other connectivity-centric cloud-enabled systems.
Its key product, Telran, the world's lowest power radio system-on-chip forms the basis for Toumaz UK's Sensium platform.
Toumaz is an AIM listed company (AIM: TMZ) with development centres in Abingdon, UK and Taipei City, Taiwan.